Autopsy report · NCT03823443

COPD Exacerbation Blood and Urine Biomarkers Study

“Difficulty enrolling”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• Ran for about 2 years 7 months before it stopped.
• 7 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Columbia University

Sponsor type

University, hospital or other

Conditions

Chronic Obstructive Pulmonary Disease; Acute Exacerbation Copd; Alpha-1 Anti-trypsin Deficiency

Participants

7

Sites

1

Countries

United States

Trials that died the same way

• Ambulatory Blood Pressure and the Normal Increase in Maternal Blood Pressure Postpartum
  “Unable to enroll” (89% match in meaning)
• A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
  “difficulty in enrollment” (89% match in meaning)
• Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
  “Difficulty with enrollment” (88% match in meaning)
• Multiparametric Ultrasound Study in Diagnosing GvHD
  “Failure to enroll” (88% match in meaning)
• Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)
  “Difficult enrollment” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.